Abstract
The chronic inflammatory process including cytomegalovirus (CMV) infection has been hypothesized to induce the progression of atherosclerosis in coronary heart disease (CHD). Numbers studies were conducted to analyze the association between CMV infection and risk of CHD, but no clear consensus had been reached. To assess this relationship more precisely, a meta-analysis was performed. The electronic databases PubMed, Embase, and CNKI were searched; data were extracted and analyzed independently by two investigators. Ultimately, 55 studies, involving 9,000 cases and 8,608 controls from six prospective studies (all with a nested case–control design) and 49 retrospective case–control studies were included. Overall, people exposed to CMV infection had an odds ratio (OR) of 1.67 (95% CI, 1.56–1.79) for CHD risk, relative to those not exposed. CMV infection was clearly identified as a risk factor for CHD in both prospective studies (OR, 1.31; 95% CI, 1.132–1.517) and retrospective studies (OR, 1.79; 95% CI, 1.659–1.939), and in both Asian group (OR, 2.69; 95% CI, 2.304–3.144) and non-Asian group (OR, 1.48; 95% CI, 1.371–1.600). Interestingly, in the subgroup analyses by detection methods of CMV, the increased risk (OR, 8.121) was greater among studies using polymerase chain reaction than the risk (OR, 1.561) among studies using enzyme-linked immunosorbent assay. In conclusion, this meta-analysis suggested that CMV infection is associated with an increased risk for CHD, especially among Asian populations.
Similar content being viewed by others
References
Higgins JP (2003) Chlamydia pneumoniae and coronary artery disease: the antibiotic trials. Mayo Clin Proc 78:321–332
Castelli W (1984) Epidemiology of coronary artery disease. Am J Med 76:4–12
Vojdani A (2003) A look at infectious agents as a possible causative factor in cardiovascular disease: part I. Lab Med 34:203–212
Fong IW (2000) Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 163:49–56
Cunningham P (2000) Is coronary artery disease an infectious disease? J Inf Pharmacother 2:320–325
LaBiche R, Koziol D, Quinn TC et al (2001) Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 32:855–860
DeGraba TJ (2004) Immunogenetic susceptibility of atherosclerotic stroke implications on current and future treatment of vascular inflammation. Stroke 35:2712–2719
Zhou YF, Shou M, Guetta E et al (1999) Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation 100:1569–1575
Muhlestein JB, Anderson JL, Hammond EH et al (1998) Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97:633–636
Adam E, Melnick JL, Probtsfield JL et al (1987) High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 2:291–293
Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15–17
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629–634
Cour MI, López de Atalaya FJ et al (1989) Lack of serological association between herpesvirus and atherosclerosis. Lancet 1:279
McDonald K, Rector TS, Braulin EA et al (1989) Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 64:359–362
Balk AH, Weimar W, Rothbarth PH et al (1993) Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience. Infection 21:195–200
Nieto FJ, Adam E, Sorlie P et al (1996) Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94:922–927
Li BQ, Xu C, Wang Q et al (1996) The detection of the antibodies of human cytomegalovirus in sera of patients with coronary heart disease [in Chinese]. Chin J Intern Med 35:741–743
Shan JK, Li LY, Li G (1996) The Preliminary report on the detection of Cytomegalovirus antibody in coronary heart disease [in Chinese]. Pract Geriatr 10:233
Zhao L, Shao LH, Yang YP et al (1997) Study of Human Cytomegalovirus antibody level in Patients with coronary heart diseases [in Chinese]. Acta Acad Med Shandong 35:351–352
Adler SP, Hur JK, Wang JP (1998) Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis 177:209–212
Fang JC, Kinlay S, Kundsin R et al (1998) Chlamydia pneumoniae infection is frequent but not associated with coronary arteriosclerosis in cardiac transplant recipients. Am J Cardiol 82:1479–1483
Ossewaarde JM, Feskens EJ, De Vries A et al (1998) Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 120:93–99
Anderson JL, Carlquist JF, Muhlestein JB et al (1998) Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 32:35–41
Blum A, Giladi M, Weinberg M et al (1998) High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 81:866–868
Feng JX, Bao GL, Jiang XF et al (1998) The detection of cytomegalovirus in the peripheral blood cells of patients with coronary heart disease [in Chinese]. J Clin Cardiol 14:79–80
Ridker PM, Hennekens CH, Stampfer MJ et al (1998) Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 98:2796–2799
Danesh J, Wong Y, Ward M et al (1999) Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease. Heart 81:245–247
Kaftan HA, Kaftan O, Kiliç M (1999) Markers of chronic infection and inflammation. Are they important in cases with chronic coronary heart disease. Jpn Heart J 40:275–280
Rothenbacher D, Hoffmeister A, Bode G et al (1999) Cytomegalovirus infection and coronary heart disease: results of a german case-control study. J Infect Dis 179:690–692
Strachan DP, Carrington D, Mendall MA et al (1999) Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study. Heart 81:248–251
Huang CX, Li GS, Li JJ et al (1999) Relationship of cytomegalovirus infection and coronary heart disease [in Chinese]. J Chin Cardiovasc Pulm Dis 18:245–247
Li JJ, Huang CX, Li GS (1999) Significance and detection of human cytomegalovirus dna in patients with coronary heart disease [in Chinese]. J Clin cardiol 15:230
Su M, Bian YS, Wang ML (1999) The relationship between Cytomegalovirus Infection and Coronary heart disease [in Chinese]. Chin J Intern Med 38:13
Ammarm P, Maarsehall S, Kraus M et al (2000) Characteristics and prognosis of myocardial infarction in patients with normal coronary arteries. Chest 117:333–338
Bai L, Ma AQ, Yan H (2000) A preliminary study on antiphospholipid antibody in coronary heart disease and its relation [in Chinese]. Chin Circ J 15:148–150
Chen YF, Du XQ, Cai YY et al (2000) The Clinical Significance of Detection of Human Cytomegalovirus in Patients with Coronary Heart Dieases [in Chinese]. Chin J Arterioscler 8:154–156
Siscovick DS, Schwartz SM, Corey L et al (2000) Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the Cardiovascular Health Study. Circulation 102:2335–2340
Dong Y, Sun X, Ning B et al (2000) Assessment of serology for detection of chlamydia pneumoniae and cytomegalovirus in patients with acute coronary syndrome [in Chinese]. S Chin J Cardiol 6:237–239
Hu LW, Liu JZ, Niu SQ et al (2000) Prevalence of present cytomegalovirus in the atherosclerosis arterial walls and leucocytes of the patients with coronary heart disease [in Chinese]. Chin J Arterioscler 8:263–265
Song WQ, Yao L, Zhang Z (2000) Clinical significance of detection of serum HCMV and AECA antibody [in Chinese]. Shanghai J Med Lab Sci 15:211–212
Du XQ, Cai YY, Chen YF et al (2000) Clinical significance of detection of human cytomegalovirus infection in patients with acute coronary syndrome [in Chinese]. Chin J Hypertens 8:210–211
Smieja M, Cronin L, Levine M et al (2001) Previous exposure to Chlamydia pneumoniae, Helicobacter pylori and other infections in Canadian patients with ischemic heart disease. Can J Cardiol 17:270–276
Deng HP, Wang ZH, Dong JH (2001) Significance and mechanism of human cytomegalovirus infection in coronary atherosclerotic heart disease [in Chinese]. J Clin Cardiol 17:70–72
Hoffmeister A, Rothenbacher D, Bode G et al (2001) Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol 21:427–432
De Backer J, Mak R, De Bacquer D et al (2002) Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis 160:457–463
Bloemenkamp DG, Mali WP, Tanis BC et al (2002) Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women. Atherosclerosis 163:149–156
Witherell HL, Smith KL, Friedman GD et al (2003) C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction. Ann Epidemiol 13:170–177
Georges JL, Rupprecht HJ, Blankenberg S et al (2003) AtheroGene Group. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol 92:515–521
Sun YR, Guo JR, Liu GL (2003) Clinical study of the relationship between human cytomegalovirus infection and coronary heart disease [in Chinese]. Chin J Prim Med Pharm 10:859–860
Altannavch Ts, Roubalová K, Broz J et al (2003) Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris. Cent Eur J Public Health 11:102–106
Timóteo A, Ferreira J, Paixão P et al (2003) Serologic markers for cytomegalovirus in acute coronary syndromes. Rev Port Cardiol 22:619–631
Chen R, Xiong S, Yang Y et al (2003) The relationship between human cytomegalovirus infection and atherosclerosis development. Mol Cell Biochem 249:91–96
Tang XD, Zhu QF, Zhou KY (2004) Human cytomegalovirus infection: an independent risk factor of coronary heart disease [in Chinese]. Chin J Clin Rehabil 8:5982–5983
Arcari CM, Gaydos CA, Nieto FJ et al (2005) Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the United States military: the importance of timing of exposure measurement. Clin Infect Dis 40:1123–1130
Sheehan J, Kearney PM, Sullivan SO et al (2005) Acute coronary syndrome and chronic infection in the Cork coronary care case-control study. Heart 91:19–22
Sun Y, Pei W, Welte T et al (2005) Cytomegalovirus infection is associated with elevated interleukin-10 in coronary artery disease. Atherosclerosis 179:133–137
Eryol NK, Kiliç H, Gül A et al (2005) Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease? Int Heart J 46:205–209
Wang XM, Li Y, Huang C et al (2005) Changes of serum soluble P-selectin and tumor necrotic factor-alpha in patients with CMV induced acute coronary syndrome [in Chinese]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 19:149–151
Liu JG, Yang QL, Ji HB et al (2006) Antigen test results and clinical significance of Cytomegalovirus in peripheral blood of patients with coronary heart disease [in Chinese]. Prac J Med 22:788–789
Kaehler J, Tuleweit A, Steven D et al (2006) Association between eotaxin (CCL11), C-reactive protein, and antimicrobial antibodies in patients undergoing coronary angioplasty. J Investig Med 54:446–454
Gredmark S, Jonasson L, Van Gosliga D et al (2007) Active cytomegalovirus replication in patients with coronary disease. Scand Cardiovasc J 41:230–234
Jha HC, Prasad J, Mittal A (2008) High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker. Heart Vessels 23:390–396
Guo T, Xu YH, Wang ZH et al (2008) The clinical study of human cytomegalovirus infection in patients with coronary heart disease [in Chinese]. Southwest Def Med 18:529–530
Safaie N, Ghotaslou R, Montazer Ghaem H (2010) Seroprevalence of cytomegalovirus in patients with and without coronary artery diseases at Madani Heart Center, Iran. Acta Med Iran 48:403–406
Wang WM (2011) Increased IL-10 correlated with human cytomegalovirus infection in patients with coronary heart disease [in Chinese]. J Guiyang Hosp TCM 33:52–56
Alavi SM, Adel SM, Rajabzadeh AR (2011) An evidence against the effect of chronic cytomegalovirus infection in unstable angina pectoris. Acta Med Iran 49:78–80
Bodurtha J, Adler SP, Nance WE (1988) Seroepidemiology of cytomegalovirus and herpes simplex virus in twins and their families. Am J Epidemiol 128:268–276
Benditt EP, Barrett T, McDougal JK (1993) Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 80:6386–6389
Minick CR, Fabricant CG, Fabricant J, Litrenta MM (1979) Athero-arteriosclerosis induced by infection with a herpesvirus. Am J Pathol 96:673–706
Van Dam-Mieras MC, Bruggeman CA, Muller AD, Debie WH, Zwaal RF (1987) Induction of endothelial cell procoagulant activity by cytomegalovirus infection. Thromb Res 47:69–75
Kowalski M, Pawlik M, Konturek JW, Konturek SJ (2006) Helicobacter pylori infection in coronary artery disease. J Physiol Pharmacol 57:101–111
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Ji, YN., An, L., Zhan, P. et al. Cytomegalovirus infection and coronary heart disease risk: a meta-analysis. Mol Biol Rep 39, 6537–6546 (2012). https://doi.org/10.1007/s11033-012-1482-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-1482-6